| Author, Year | Title | Randomization | Double Blinding | Withdrawals and Dropouts | Total | ||||
|
Is There Any Reference to Randomization?
(Yes/No: 1/0) |
Is the Randomization Method Appropriate?
(Yes/No: 1/0) |
Is the Randomization Method Inappropriate?
(Yes/No: −1/0) |
Is There Any Reference to Double-Blind Testing? (Yes/No: 1/0) | Is the Double-Blind Method Appropriate? (Yes/No: 1/0) | Is the Double-Blind Method Inappropriate? (Yes/No: −1/0) |
Is There a Description of Participants Who Discontinued or Dropped Out (Number and Reason)?
(Yes/No: 1/0) |
|||
| Chiewchalermsri et al., 2024 [29] | Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in the build-up phase of house dust mite-specific immunotherapy. | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 4 |
| Guo, 2023 [16] | Vitamin D supplementation improves the therapeutic effect of mometasone on allergic rhinitis. | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 |
| Bhardwaj and Singh, 2021 [28] | Efficacy of vitamin D supplementation in allergic rhinitis. | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Bakhshaee et al., 2019 [19] | Therapeutic effect of vitamin D supplementation on allergic rhinitis. | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 5 |
| Jerzynska et al., 2016 [30] | The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 5 |